Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

A direct determination of thymidine triphosphate concentrations without dephosphorylation in peripheral blood mononuclear cells by LC/MS/MS.

Chi J, Jayewardene A, Stone J, Gambertoglio JG, Aweeka FT.

J Pharm Biomed Anal. 2001 Dec;26(5-6):829-36.

PMID:
11600294
2.

An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma.

Jayewardene AL, Kearney B, Stone JA, Gambertoglio JG, Aweeka FT.

J Pharm Biomed Anal. 2001 May;25(2):309-17.

PMID:
11275438
3.

Liquid chromatographic determination of urinary 6beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women.

Homma M, Beckerman K, Hayashi S, Jayewardene AL, Oka K, Gambertoglio JG, Aweeka FT.

J Pharm Biomed Anal. 2000 Sep;23(4):629-35.

PMID:
10975239
4.

Removal of Foscarnet by hemodialysis using dialysate-side values.

Sam R, Patel SB, Popli A, Leehey DJ, Gambertoglio JG, Ing TS.

Int J Artif Organs. 2000 Mar;23(3):165-7.

PMID:
10795660
5.

The stability of intracellular zidovudine and its anabolites in extracts of peripheral blood mononuclear cells (PBMCs).

Thevanayagam LN, Jayewardene AL, Gambertoglio JG.

J Pharm Biomed Anal. 2000 Apr;22(3):597-603. No abstract available.

PMID:
10766376
6.

Antiviral therapy for HIV patients with renal insufficiency.

Jayasekara D, Aweeka FT, Rodriguez R, Kalayjian RC, Humphreys MH, Gambertoglio JG.

J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):384-95. Review.

PMID:
10458619
7.

Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease.

Aweeka FT, Gottwald MD, Gambertoglio JG, Wright TL, Boyer TD, Pollock AS, Eldon MA, Kugler AR, Alldredge BK.

Epilepsia. 1999 Jun;40(6):777-82.

8.

Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations.

Aweeka FT, Jacobson MA, Martin-Munley S, Hedman A, Schoenfeld P, Omachi R, Tsunoda S, Gambertoglio JG.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):350-7.

PMID:
10096579
9.

Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.

Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT.

Clin Pharmacol Ther. 1999 Jan;65(1):21-8.

PMID:
9951427
10.

Comparison of zidovudine phosphorylation in lymph nodes and peripheral blood mononuclear cells in HIV-infected patients. DATRI 012 Study Group.

Peter K, Lalezari JP, Pearl JM, Thevanayagam L, Gambertoglio JG.

AIDS. 1998 Sep 10;12(13):1729-31. No abstract available.

PMID:
9764801
12.

Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma.

Jayewardene AL, Zhu F, Aweeka FT, Gambertoglio JG.

J Chromatogr B Biomed Sci Appl. 1998 Apr 10;707(1-2):203-11.

PMID:
9613951
13.

High-performance liquid chromatographic determination of pyrazoloacridine, a nitro-9-methoxyacridine anticancer agent, in human plasma.

Jayewardene AL, Santoro JE, Gambertoglio JG.

J Chromatogr B Biomed Sci Appl. 1997 Nov 21;702(1-2):203-10.

PMID:
9449572
14.

Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, Greenspan FS.

JAMA. 1997 Apr 16;277(15):1205-13.

PMID:
9103344
15.

Effect of renal impairment on the pharmacokinetics of grepafloxacin.

Efthymiopoulos C, Bramer SL, Maroli A, Gambertoglio JG.

Clin Pharmacokinet. 1997;33 Suppl 1:32-8.

PMID:
9433654
16.

Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: the effects of zidovudine.

Aweeka FT, Kwong M, Mak M, al-Uzri A, Affrime M, Cutler D, Kahn J, Gambertoglio JG.

J Clin Pharmacol. 1996 Dec;36(12):1107-13.

PMID:
9013366
17.
18.

Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1.

Wolfe EJ, Cavacini LA, Samore MH, Posner MR, Kozial C, Spino C, Trapnell CB, Ketter N, Hammer S, Gambertoglio JG.

Clin Pharmacol Ther. 1996 Jun;59(6):662-7.

PMID:
8681491
19.

Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.

Lee BL, Safrin S, Makrides V, Gambertoglio JG.

Antimicrob Agents Chemother. 1996 May;40(5):1231-6.

20.

Protein binding of clindamycin in sera of patients with AIDS.

Flaherty JF Jr, Gatti G, White J, Bubp J, Borin M, Gambertoglio JG.

Antimicrob Agents Chemother. 1996 May;40(5):1134-8.

22.

Immunopharmacodynamic studies of cyclosporine in patients awaiting renal transplantation.

d'Uscio CH, Aweeka FT, Prueksaritanont T, Tomlanovich SJ, Gupta SK, Lantz MV, Gambertoglio JG, Garovoy MR, Benet LZ.

J Clin Pharmacol. 1995 Oct;35(10):967-73.

PMID:
8568014
23.

Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis.

Lam YW, Flaherty JF, Yumena L, Schoenfeld PY, Gambertoglio JG.

J Antimicrob Chemother. 1995 Jul;36(1):157-63.

PMID:
8537262
24.

Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis.

Aweeka FT, Gambertoglio JG, Kramer F, van der Horst C, Polsky B, Jayewardene A, Lizak P, Emrick L, Tong W, Jacobson MA.

Clin Pharmacol Ther. 1995 Apr;57(4):403-12.

PMID:
7712668
25.

Determination of ticarcillin in human plasma and in urine by reversed-phase LC.

La Follette G, Jayewardene AL, Seneviratne AK, Lin ET, Gambertoglio JG.

J Pharm Biomed Anal. 1995 Feb;13(2):159-64.

PMID:
7766723
26.

Paired ion reversed-phase HPLC assay for the determination of iothalamic acid and para aminohippuric acid in urine.

Seneviratne AK, Jayewardene AL, Gambertoglio JG.

J Pharm Biomed Anal. 1994 Oct;12(10):1311-6.

PMID:
7841228
27.

Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.

Kahn JO, Gorelick KJ, Gatti G, Arri CJ, Lifson JD, Gambertoglio JG, Bostrom A, Williams R.

Antimicrob Agents Chemother. 1994 Feb;38(2):260-7.

28.

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.

Flores-Aguilar M, Kuppermann BD, Quiceno JI, Dankner WM, Wolf DG, Capparelli EV, Connor JD, Sherwood CH, Fullerton S, Gambertoglio JG, et al.

Ophthalmology. 1993 Jul;100(7):1022-31.

PMID:
8391674
29.

Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients.

Reusser P, Gambertoglio JG, Lilleby K, Meyers JD.

J Infect Dis. 1992 Sep;166(3):473-9.

PMID:
1323614
30.
31.

An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion.

al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR.

Kidney Int. 1992 Jun;41(6):1701-6. No abstract available.

32.

Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.

Kays MB, White RL, Gatti G, Gambertoglio JG.

Pharmacotherapy. 1992;12(1):50-5.

PMID:
1549539
33.

Transfer of autologous haemoglobin from the peritoneal cavity during peritoneal dialysis.

Brouard R, Tozer TN, Baumelou A, Gambertoglio JG.

Nephrol Dial Transplant. 1992;7(1):57-62.

PMID:
1316582
34.

Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex.

Gatti G, Kahn JO, Lifson J, Williams R, Turin L, Volberding PA, Gambertoglio JG.

Antimicrob Agents Chemother. 1991 Dec;35(12):2531-7.

35.
36.

Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.

Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA.

J Clin Endocrinol Metab. 1991 May;72(5):1130-5.

PMID:
1827127
37.

The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study.

Kahn JO, Kaplan LD, Gambertoglio JG, Bredesen D, Arri CJ, Turin L, Kibort T, Williams RL, Lifson JD, Volberding PA.

AIDS. 1990 Dec;4(12):1197-204.

PMID:
2088398
38.

Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.

Gupta SK, Manfro RC, Tomlanovich SJ, Gambertoglio JG, Garovoy MR, Benet LZ.

J Clin Pharmacol. 1990 Jul;30(7):643-53.

PMID:
2391396
39.

The pharmacokinetics of teicoplanin in varying degrees of renal function.

Lam YW, Kapusnik-Uner JE, Sachdeva M, Hackbarth C, Gambertoglio JG, Sande MA.

Clin Pharmacol Ther. 1990 May;47(5):655-61.

PMID:
2140543
40.

Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection.

Hassanzadeh MK, Aweeka FT, Wu S, Jacobson MA, Gambertoglio JG.

J Chromatogr. 1990 Jan 26;525(1):133-40.

PMID:
2140113
41.

Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.

Brouard RJ, Kapusnik JE, Gambertoglio JG, Schoenfeld PY, Sachdeva M, Freel K, Tozer TN.

Clin Pharmacol Ther. 1989 Jun;45(6):674-81.

PMID:
2525081
42.

Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.

Rodondi LC, Flaherty JF, Schoenfeld P, Barriere SL, Gambertoglio JG.

Clin Pharmacol Ther. 1989 May;45(5):527-34.

PMID:
2721108
43.

Pharmacokinetics of esmolol and ASL-8123 in renal failure.

Flaherty JF, Wong B, La Follette G, Warnock DG, Hulse JD, Gambertoglio JG.

Clin Pharmacol Ther. 1989 Mar;45(3):321-7.

PMID:
2563962
44.

Influence of food on the absorption of albuterol Repetabs.

Bolinger AM, Young KY, Gambertoglio JG, Newth CJ, Zureikat G, Powell M, Leung P, Affrime MB, Symchowicz S, Patrick JE.

J Allergy Clin Immunol. 1989 Jan;83(1):123-6.

PMID:
2913132
45.

Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.

Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG.

Antimicrob Agents Chemother. 1988 Dec;32(12):1825-9.

46.

Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers.

Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ.

Antimicrob Agents Chemother. 1988 Mar;32(3):298-302.

47.

Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.

Flaherty JF, Barriere SL, Mordenti J, Gambertoglio JG.

Antimicrob Agents Chemother. 1987 Jun;31(6):895-8.

48.

Pharmacokinetics of cefoperazone and tobramycin alone and in combination.

Guglielmo BJ, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG.

Antimicrob Agents Chemother. 1987 Feb;31(2):264-6.

49.

Lack of effect of sucralfate on prednisone bioavailability.

Gambertoglio JG, Romac DR, Yong CL, Birnbaum J, Lizak P, Amend WJ Jr.

Am J Gastroenterol. 1987 Jan;82(1):42-5.

PMID:
3799579
50.

Comparative pharmacokinetics of low- and high-dose ticarcillin.

Guglielmo BJ, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG.

Antimicrob Agents Chemother. 1986 Sep;30(3):359-60.

Supplemental Content

Loading ...
Support Center